Latest News about XPH
Recent news which mentions XPH
   Mark Cuban Says Cutting PBM Fees Won't Reduce Pharmaceutical R&D Funding: 'Manufacturers Can Sell To Us For More'
   
  
  
  August 01, 2025
  From Benzinga
 From Benzinga
 
   Trump Threatens 200% Pharma Tariffs, But Analyst Says This Stock Is Immune And Expected To 'Benefit' From Levies
   
  
  
  July 11, 2025
  From Benzinga
 From Benzinga
 From Benzinga
 From Benzinga
 
   A Look At Pharma ETFs After Strong Q1 Earnings
   
  
  
  May 08, 2025
  From TalkMarkets
 
   Are Your Health Care ETFs Safe? Trump's New Policies May Trigger Shockwaves Across Pharma Stocks
   
  
  
  May 08, 2025
  From Benzinga
 
   ETF Shake-Up: UNH's Meltdown Meets LLY's Moonshot
   
  
  
  April 18, 2025
  From Benzinga
 
   Eli Lilly, AbbVie, Bristol Myers, Regeneron, And Other Pharma Companies Slide As Donald Trump Confirms Tariffs On Pharma Companies
   
  
  
  April 11, 2025
  From Benzinga
 
   Biopharma: A 'Safe Haven' As Tariff Turmoil Rages On?
   
  
  
  April 03, 2025
  From Benzinga
 
   Perrigo Outlines 2025 Growth Plans, Projects Sales Boost And Margin Expansion By 2027
   
  
  
  February 28, 2025
  From Benzinga
 
   Ken Griffin's Citadel Places Big Short Bet Against GSK - Here's What It Means for Investors
   
  
  
  February 17, 2025
  From Benzinga
 
   Purdue Pharma Bankruptcy Plan Rejected by Supreme Court, Billionaire Sacklers to Face Lawsuits
   
  
  
  June 27, 2024
  From Benzinga
 
   Finding Opportunity in Unloved Healthcare ETFs
   
  
  
  May 31, 2024
  From ETF Trends
 
   Organon Beats On Q1, Women's Health Leads the Charge
   
  
  
  May 02, 2024
  From Benzinga
 
   Eli Lilly’s stock soars toward best day in 23 years after strong earnings, upbeat Mounjaro outlook
   
  
  
  August 08, 2023
  From MarketWatch
 From MarketWatch
 
   FDA approves Reata’s rare disease drug amid questions about changes to the regulatory environment for neuroscience treatments
   
  
  
  February 28, 2023
  From MarketWatch
 From MarketWatch
 
   What investors need to know about Pfizer’s latest downgrade
   
  
  
  January 26, 2023
  From MarketWatch
 
   Will 2023 be the year that pharma M&A makes a comeback?
   
  
  
  January 12, 2023
  From MarketWatch
 
   As COVID vaccine and Paxlovid sales decline, analysts want to know what’s next for Pfizer
   
  
  
  January 04, 2023
  From MarketWatch
 From MarketWatch
 
   Is It Too Late to Buy AbbVie Stock?
   
  
  
  May 17, 2022
  From Motley Fool
 
   7 Pharmaceutical Stocks That Could Make You Rich
   
  
  
  January 06, 2022
  From InvestorPlace
 
   Is It Too Late to Buy AbbVie Stock?
   
  
  
  December 14, 2021
  From Motley Fool
 
   The U.S. stock market suffers ugly Black Friday selloff. Here are the biggest losers (and winners)
   
  
  
  November 26, 2021
  From MarketWatch
 
   Is Now the Time to Ditch Pharma Stocks?
   
  
  
  September 21, 2021
  From Motley Fool
 
   2 Pharma Stocks You Can Buy and Hold for the Next Decade
   
  
  
  September 16, 2021
  From Motley Fool
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.